
Response Oncology, Inc.
Aktie · US7612323052 (OTC)
Kein Kurs
n/a
Firmenprofil zu Response Oncology, Inc. Aktie
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Neuste KI Analysen zu Response Oncology, Inc.
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.
Unternehmensdaten
Name Response Oncology, Inc.
Firma Response Oncology, Inc.
Heimatbörse
UTC
ISIN US7612323052
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Care Facilities
CEO Charles E. Sweet
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
IPO Datum 2000-01-03
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | ROIX |
Weitere Aktien
Investoren, die Response Oncology, Inc. halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.


